Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity.
Elyanow R, Snyder TM, Dalai SC, Gittelman RM, Boonyaratanakornkit J, Wald A, Selke S, Wener MH, Morishima C, Greninger AL, Gale M Jr, Hsiang TY, Jing L, Holbrook MR, Kaplan IM, Zahid HJ, May DH, Carlson JM, Baldo L, Manley T, Robins HS, Koelle DM. Elyanow R, et al. Among authors: boonyaratanakornkit j. JCI Insight. 2022 May 23;7(10):e150070. doi: 10.1172/jci.insight.150070. JCI Insight. 2022. PMID: 35439166 Free PMC article.
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Boonyaratanakornkit J, et al. medRxiv [Preprint]. 2020 Oct 21:2020.10.06.20207472. doi: 10.1101/2020.10.06.20207472. medRxiv. 2020. PMID: 33052361 Free PMC article. Updated. Preprint.
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Lukin VV, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Boonyaratanakornkit J, et al. J Clin Invest. 2021 Feb 1;131(3):e144930. doi: 10.1172/JCI144930. J Clin Invest. 2021. PMID: 33320842 Free PMC article. Clinical Trial.
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19.
Phan IQ, Subramanian S, Kim D, Murphy M, Pettie D, Carter L, Anishchenko I, Barrett LK, Craig J, Tillery L, Shek R, Harrington WE, Koelle DM, Wald A, Veesler D, King N, Boonyaratanakornkit J, Isoherranen N, Greninger AL, Jerome KR, Chu H, Staker B, Stewart L, Myler PJ, Van Voorhis WC. Phan IQ, et al. Among authors: boonyaratanakornkit j. Sci Rep. 2021 Feb 22;11(1):4290. doi: 10.1038/s41598-021-83730-y. Sci Rep. 2021. PMID: 33619344 Free PMC article.
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.
Walti CS, Krantz EM, Maalouf J, Boonyaratanakornkit J, Keane-Candib J, Joncas-Schronce L, Stevens-Ayers T, Dasgupta S, Taylor JJ, Hirayama AV, Bar M, Gardner RA, Cowan AJ, Green DJ, Boeckh MJ, Maloney DG, Turtle CJ, Hill JA. Walti CS, et al. Among authors: boonyaratanakornkit j. JCI Insight. 2021 Jun 8;6(11):e146743. doi: 10.1172/jci.insight.146743. JCI Insight. 2021. PMID: 33914708 Free PMC article.
Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
Stewart J, Krows ML, Schaafsma TT, Heller KB, Brown ER, Boonyaratanakornkit J, Brown CE, Leingang H, Liou C, Bershteyn A, Schwartz MD, Agrawal V, Friedman-Klabanoff D, Eustace S, Stankiewicz Karita HC, Paasche-Orlow MK, Kissinger P, Hosek SG, Chu HY, Celum C, Baeten JM, Wald A, Johnston C, Barnabas RV. Stewart J, et al. Among authors: boonyaratanakornkit j. JAMA Netw Open. 2022 Feb 1;5(2):e2148325. doi: 10.1001/jamanetworkopen.2021.48325. JAMA Netw Open. 2022. PMID: 35157053 Free PMC article.
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapy.
Gonzalez MA, Bhatti AM, Fitzpatrick K, Boonyaratanakornkit J, Huang ML, Campbell VL, Hecht J, Ibrahimi S, Wanner SN, Green DJ, Maloney DG, Gauthier J, Cowan AJ, Greninger AL, Krantz EM, Koelle DM, Hill JA. Gonzalez MA, et al. Among authors: boonyaratanakornkit j. Blood Adv. 2023 May 9;7(9):1849-1853. doi: 10.1182/bloodadvances.2022008338. Blood Adv. 2023. PMID: 36094846 Free PMC article. No abstract available.
Protective antibodies against human parainfluenza virus type 3 infection.
Boonyaratanakornkit J, Singh S, Weidle C, Rodarte J, Bakthavatsalam R, Perkins J, Stewart-Jones GBE, Kwong PD, McGuire AT, Pancera M, Taylor JJ. Boonyaratanakornkit J, et al. MAbs. 2021 Jan-Dec;13(1):1912884. doi: 10.1080/19420862.2021.1912884. MAbs. 2021. PMID: 33876699 Free PMC article.
Immune signatures underlying post-acute COVID-19 lung sequelae.
Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, Wang Z, Wei X, Tang J, Li Y, Marlow H, Hughes S, Hammel L, Cox TM, Goddery E, Ayasoufi K, Weiskopf D, Boonyaratanakornkit J, Dong H, Li H, Chakraborty R, Johnson AJ, Edell E, Taylor JJ, Kaplan MH, Sette A, Bartholmai BJ, Kern R, Vassallo R, Sun J. Cheon IS, et al. Among authors: boonyaratanakornkit j. Sci Immunol. 2021 Nov 12;6(65):eabk1741. doi: 10.1126/sciimmunol.abk1741. Epub 2021 Nov 12. Sci Immunol. 2021. PMID: 34591653 Free PMC article. Clinical Trial.
61 results